MacroGenics, Inc. - Common Stock (NQ:MGNX)

2.440 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MacroGenics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

March 09, 2023

Via Benzinga

MacroGenics Announces Sale of TZIELD™ Royalty Interest for up to $200 Million

March 08, 2023

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call

March 07, 2023

From MacroGenics, Inc.

Via GlobeNewswire

The Latest Analyst Ratings for Macrogenics ↗

January 19, 2023

Via Benzinga

7 Analysts Have This to Say About Macrogenics ↗

November 23, 2022

Via Benzinga

Expert Ratings for Macrogenics ↗

November 23, 2022

Via Benzinga

What 7 Analyst Ratings Have To Say About Macrogenics ↗

November 23, 2022

Via Benzinga

Where Macrogenics Stands With Analysts ↗

November 23, 2022

Via Benzinga

Why Shares of MacroGenics Were Dropping Tuesday ↗

November 22, 2022

Profit-taking and an analyst downgrade affected the stock's price.

Via The Motley Fool

MacroGenics to Participate in Upcoming Investor Conferences

March 02, 2023

From MacroGenics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 17, 2023

Via Benzinga

AutoNation, HubSpot, AMC Networks And Other Big Stocks Moving Higher On Friday ↗

February 17, 2023

U.S. stocks traded lower, with the Nasdaq Composite dropping over 100 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Around $11M Bet On Insight Enterprises? Check Out These 4 Stocks Insiders Are Buying ↗

February 17, 2023

Although US stocks closed lower on Thursday, there were a few notable insider trades.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 14, 2023

Via Benzinga

MacroGenics Posts Interim Data From Lorigerlimab Study In Prostate Cancer Patients ↗

February 14, 2023

Via Benzinga

MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium

February 13, 2023

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

February 06, 2023

From MacroGenics, Inc.

Via GlobeNewswire

Tesla To Rally Around 138%? Here Are 10 Other Analyst Forecasts For Thursday ↗

January 19, 2023

JP Morgan cut the price target for Apple Inc. (NASDAQ: AAPL) from $190 to $180. JP Morgan analyst Samik Chatterjee maintained an Overweight rating. Apple shares fell 1.1% to $133.70 in pre-market...

Via Benzinga

MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 04, 2023

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics Announces Appointment of Dr. Margaret Liu and Meenu Chhabra Karson to Board of Directors

January 04, 2023

From MacroGenics, Inc.

Via GlobeNewswire

$5 Million Bet On IAC? Check Out These 3 Stocks Insiders Are Buying ↗

November 28, 2022

Although US stocks closed mixed on Friday, there were a few notable insider trades.

Via Benzinga

Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56% ↗

November 23, 2022

Mizuho cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $180. Mizuho analyst James Lee maintained the stock with a Buy rating. Baidu shares rose 2.5% to trade at $97.49 on Wednesday.

Via Benzinga

Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box ↗

November 23, 2022

Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to...

Via Benzinga

See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch ↗

November 23, 2022

Sales accelerated, again, in the third quarter. Here's what the company and analysts are watching.

Via Investor's Business Daily

Dow Jumps Over 300 Points; S&P 500 Rises 1% ↗

November 22, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Tuesday.

Via Benzinga

Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session ↗

November 22, 2022

Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel...

Via Benzinga

Crude Oil Surges 2%; Best Buy Posts Upbeat Earnings ↗

November 22, 2022

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 250 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 22, 2022

Via Benzinga

US Stocks Open Higher As Dow Surges 250 Points ↗

November 22, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Tuesday.

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.